2Mundt AJ,Lujan AE,Rotmensch J,et al.Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies[J].Int J Radiat Oncol Biol Phys,2002,52 (5):1330-1337.
3Mundt AJ,Mell LK,Roeske JC.Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy[J].Int J Radiat Oncol Biol Phys,2003,56 (5):1354-1360.
4Brixey CJ,Roeske JC,Lujan AE,et al.Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies[J].Int J Radiat Oncol Biol Phys,2002,54(5):1388-1396.
6Mar'ina LA,Chekhonadskii VN,Kravets OA,et al.Comparison of effectiveness of treatment for cervical carcinoma using different brachytherapy equipment[J].Vopr Onkol,2004,50(1):55-60.
7Tacev T,Ptackova B,Stmad V.Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study[J].Strahlenther Onkol,2003,179 (6):377-384.
8Wang CK,Zhang X.Compound dual radiation action theory for 252 Cf brachytherapy[J].Radiat Prot Dosimetry,2004,110 (1 -4):801-806.
9Rivard MJ.Neutron dosimetry for a general 252Cf brachytherapy source[J].Med Phys,2000,27(12):2803-2815.
10Tacev T,Grigorov G,Papirek T,et al.Remote afterloading for neutron brachytherapy using californium-252[J].Strahlenther Onkol,2003,179 (2):113-117.
4Rustin GJ, Quinn M, Thigpen T, et al. New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer) [J]. J Natl Cancer Inst,2004,15(96):487-488.
5Szantho PA, Mayer A. Experience in first line chemotherapy with paclitaxel for the treatment of ovarian carcimomas [J]. Orv Hetil,2003,144(19): 919-924.
6Jemal AR, Siegel E. Cancer statistics 2007, CA Cancer [J]. Clin,2007,57 (1):43-66.
7Pectasides E, Sykiotis C, Koumarianou A, et al. CarboPlatin and Paelitaxel for the treatment of advanced or recurrent endometrial cancer [J]. Am J Obstet Gynecol,2005,192(5):1365-1367.
